experimental drug blocking male hormone effects
Proxalutamide is an experimental drug that acts as a nonsteroidal antiandrogen, meaning it blocks the effects of androgens (male hormones) like testosterone. It is being studied for its potential use in treating conditions like prostate cancer and androgenetic alopecia (a common form of hair loss), by inhibiting the androgen receptors that contribute to these conditions.
— no results